ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaarBiogen Switzerland AG
Biogen Switzerland AG Logo
Verified· 3 sources

Biogen Switzerland AG

Summary

About the company

The core activity of Biogen is the research, development and production of medicines, in particular large and small molecular therapeutics, as well as biosimilars, with a focus on the treatment of severe diseases such as neurology, neuropsychiatry, immunology and rare diseases.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered7
Medicines
Medicines for neurology, immunology and rare diseases, including therapies for multiple sclerosis, Alzheimer’s disease, SMA, ALS, Friedreich ataxia, lupus and kidney disease.
Clinical Trials
Clinical trials in neurologic and immunologic diseases to test the safety and effectiveness of investigational therapies, with participation from patients, families and healthcare professionals.
Pipeline
Development pipeline of potential therapies in neurology, immunology and rare diseases, including programs for Alzheimer’s disease, multiple sclerosis, lupus, Friedreich ataxia, SMA, ALS and kidney disease.
Early Access to Therapies
Early access to investigational or not-yet-approved therapies for serious diseases when no suitable alternative exists and local legal requirements are met.
Biopharmaceutical Manufacturing
Development, manufacturing and delivery of medicines with quality control, process development, global supply chain expertise and production sites in the U.S. and Switzerland.
Medical Information
Medical information for healthcare professionals, patients and caregivers on products and benefit-risk questions, via phone, email and a medical information portal.
Partnerships and Licensing
Partnerships, collaborations, acquisitions and licensing models to develop and commercialize new medicines in neurology, immunology, nephrology and rare diseases.
Press

Media

October 25, 2024Media
Biotech-Konzern Biogen entlässt erneut Mitarbeiter in Baar ZG
blick.ch
May 29, 2017Media
Pharmafirma am Jurasüdfuss - Gigantisch: Biogen-Neubau in Luterbach aussen fertig gebaut
srf.ch
July 1, 2015Media
Aargau Solothurn - Biogen bringt neues Leben auf die Industriebrache
srf.ch
Comparisons

Biogen Switzerland AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Biogen Switzerland AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Biogen Switzerland AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Neuhofstrasse 30
6340 Baar

At a glance

Legal form
Corporation
UID
CHE-108.460.535
Founded
1996 · 30 years
Last commercial register change
July 9, 2026
Employees
51 to 100

Knowledge

No knowledge articles yet

Once Biogen Switzerland AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AP
Alexion Pharma GmbH
Baar
FS
FyoniBio SA
Baar
CL
Centenara Labs AG
Baar
AS
Alnylam Switzerland GmbH
Zug
AI
Apellis International GmbH
Zug
JP
Jazz Pharmaceuticals Switzerland GmbH
Zug
ME
Meditrial Europe AG
Zug
NT
Nektar Therapeutics Europe GmbH
Zug